Brief: Plx Pharma Inc. Reports Third Quarter 2020 Results And Provides Business Update
16/11/2020 23:22
PLx Pharma Inc PLXP.O :
* . REPORTS THIRD QUARTER 2020 RESULTS AND PROVIDES BUSINESS
UPDATE
* Q3 LOSS PER SHARE $0.40
* ON TARGET FOR Q3 2021 COMMERCIAL LAUNCH OF VAZALORE
* RECOGNIZED NO REVENUE FOR THREE MONTHS ENDED SEPTEMBER 30,
2020
Source text for Eikon: ID:nGNX6nHB8G
Further company coverage: PLXP.O
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice